Coloplast : Q2 23: Inflation and supply chain headwinds continue to bite

EARNINGS/SALES RELEASESColoplast has reported a 8% rise in Q2 23 revenue, driven by double-digit growth in wound and skin care, and in interventional urology. However, gross margin erosion and higher... | May 11, 2023

Related Keywords

,Coloplastas Stock Exchange ,News ,Information ,Press Release ,Eleasescoloplast ,Gas ,Eported ,Rise ,N ,2 ,3 ,Riven ,Y ,Growth ,Hound ,End ,Skin ,Interventional ,Cross ,Margin ,Erosion ,Nd Colob Dk0060448595 ,